288 related articles for article (PubMed ID: 9087680)
1. Physiological role of nitric oxide in regulation of renal function in humans.
Haynes WG; Hand MF; Dockrell ME; Eadington DW; Lee MR; Hussein Z; Benjamin N; Webb DJ
Am J Physiol; 1997 Mar; 272(3 Pt 2):F364-71. PubMed ID: 9087680
[TBL] [Abstract][Full Text] [Related]
2. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Bech JN; Nielsen CB; Pedersen EB
Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
[TBL] [Abstract][Full Text] [Related]
4. Role of nitric oxide in the arterial pressure and renal adaptations to long-term changes in sodium intake.
Manning RD; Hu L; Reckelhoff JF
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1162-9. PubMed ID: 9140016
[TBL] [Abstract][Full Text] [Related]
5. Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans.
Dijkhorst-Oei LT; Koomans HA
Nephrol Dial Transplant; 1998 Mar; 13(3):587-93. PubMed ID: 9550632
[TBL] [Abstract][Full Text] [Related]
6. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Diamant M; Joles JA; van Raalte DH
Diabetes Obes Metab; 2016 Feb; 18(2):178-85. PubMed ID: 26636423
[TBL] [Abstract][Full Text] [Related]
7. Effects of nitric oxide blockade and cyclosporin A on cardiovascular and renal function in normal man.
Hansen JM; Johansen NJ; Mollerup HM; Fogh-Andersen N; Strandgaard S
J Hypertens; 1999 Dec; 17(12 Pt 1):1707-13. PubMed ID: 10658936
[TBL] [Abstract][Full Text] [Related]
8. Effects of sodium intake on the pressor and renal responses to nitric oxide synthesis inhibition in normotensive individuals with different sodium sensitivity.
Barba G; Vallance PJ; Strazzullo P; MacAllister RJ
J Hypertens; 2000 May; 18(5):615-21. PubMed ID: 10826565
[TBL] [Abstract][Full Text] [Related]
9. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
[TBL] [Abstract][Full Text] [Related]
10. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of NO-inhibition in patients with cirrhosis vs. healthy controls: a randomized placebo-controlled crossover study.
Bech JN; Aagaard NK; Pedersen RS; Sorensen TB; Vilstrup H; Pedersen EB
Liver Int; 2014 Feb; 34(2):211-9. PubMed ID: 23809512
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats.
Kvam FI; Ofstad J; Iversen BM
Kidney Blood Press Res; 2000; 23(6):376-84. PubMed ID: 11070417
[TBL] [Abstract][Full Text] [Related]
13. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.
Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB
Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans.
Dijkhorst-Oei LT; Rabelink TJ; Boer P; Koomans HA
Hypertension; 1997 May; 29(5):1192-8. PubMed ID: 9149686
[TBL] [Abstract][Full Text] [Related]
15. Effects of endothelin on renal hemodynamics and excretory functions in anesthetized dogs.
Tsuchiya K; Naruse M; Sanaka T; Naruse K; Kato Y; Zeng ZP; Nitta K; Shizume K; Demura H; Sugino N
Life Sci; 1990; 46(1):59-65. PubMed ID: 2405231
[TBL] [Abstract][Full Text] [Related]
16. Renal and hormonal effects of systemic nitric oxide inhibition in patients with congestive heart failure and in healthy control subjects.
Bech JN; Starklint J; Bentzen H; Nyvad O; Pedersen EB
J Card Fail; 2013 Nov; 19(11):776-85. PubMed ID: 24263123
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function.
Perrella MA; Hildebrand FL; Margulies KB; Burnett JC
Am J Physiol; 1991 Aug; 261(2 Pt 2):R323-8. PubMed ID: 1877690
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide synthesis inhibition does not impair water immersion-induced renal vasodilation in humans.
Dijkhorst-Oei LT; Boer P; Rabelink TJ; Koomans HA
J Am Soc Nephrol; 2000 Jul; 11(7):1293-1302. PubMed ID: 10864586
[TBL] [Abstract][Full Text] [Related]
19. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.
Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB
Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-2 receptor blockade potentiates the renal effects of nitric oxide inhibition in humans.
Montanari A; Tateo E; Fasoli E; Donatini A; Cimolato B; Perinotto P; Dall'Aglio P
Hypertension; 1998 Jan; 31(1 Pt 2):277-82. PubMed ID: 9453316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
